26 Feb 2020 360Dx feature: ‘Avacta Eyes Diagnostic Applications for Alternative to Antibody-Based Reagents’ News | Reagents & Diagnostics
12 Feb 2020 Alastair Smith provides overview of pre|CISION™ prodrug technology and update on AVA6000 clinical trial Investors | Therapeutics
03 Feb 2020 Avacta and Daewoong Agree Collaboration and License Agreement with AffyXell Therapeutics News | Therapeutics
28 Jan 2020 Successful initial proof-of-concept for a proprietary new class of anti-cancer therapy Investors | Therapeutics